Zemin Cao Selected Research

Zemin Cao Research Topics

Disease

8	Albuminuria 09/2004 - 04/2002
7	Diabetic Nephropathies (Diabetic Nephropathy) 08/2011 - 01/2002
3	Fibrosis (Cirrhosis) 09/2010 - 09/2004
3	Atherosclerosis 05/2004 - 07/2002
3	Hypertension (High Blood Pressure) 01/2003 - 01/2002
3	Proteinuria 07/2002 - 01/2002
2	Myocardial Infarction 08/2012 - 10/2005
2	Hypertrophy 10/2005 - 04/2003
1	Infections 04/2024
1	Neoplasms (Cancer) 04/2024
1	Pathologic Processes 04/2024
1	Chromosome Aberrations (Chromosome Abnormalities) 11/2017
1	Type 2 Diabetes Mellitus (MODY) 08/2012
1	Stroke (Strokes) 08/2012
1	Coronary Artery Disease (Coronary Atherosclerosis) 08/2012
1	Peripheral Arterial Disease 08/2012
1	Discoid Lupus Erythematosus 09/2010
1	Cicatrix (Scar) 10/2005
1	Vascular Diseases (Vascular Disease) 05/2004
1	Diabetic Retinopathy (Retinopathy, Diabetic) 02/2004
1	Retinal Diseases 02/2004
1	Retinopathy of Prematurity (Retrolental Fibroplasia) 09/2003
1	Ganglion Cysts (Ganglion) 09/2003
1	Cardiomegaly (Heart Hypertrophy) 04/2003

Drug/Important Bio-Agent (IBA)

4	Amlodipine (Norvasc)FDA LinkGeneric 09/2004 - 01/2003
3	Valsartan (Vals)FDA Link 10/2005 - 07/2002
3	Connective Tissue Growth FactorIBA 10/2005 - 07/2002
3	Proteins (Proteins, Gene)FDA Link 10/2005 - 05/2002
3	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 09/2004 - 01/2002
3	nephrinIBA 01/2003 - 05/2002
2	Ramipril (Altace)FDA LinkGeneric 08/2012 - 06/2003
2	AutoantigensIBA 01/2011 - 09/2010
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2011 - 10/2005
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 10/2005 - 07/2002
2	Messenger RNA (mRNA)IBA 10/2005 - 09/2003
2	CollagenIBA 10/2005 - 03/2004
2	Angiotensin IIIBA 08/2004 - 01/2003
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 05/2004 - 03/2004
2	Irbesartan FDA LinkGeneric 03/2004 - 08/2002
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 03/2004 - 07/2002
2	Calcium Channels (Calcium Channel)IBA 03/2004 - 04/2003
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2004 - 09/2003
2	PD 123319IBA 09/2003 - 07/2002
2	1,4-dihydropyridine (dihydropyridine)IBA 01/2003 - 01/2002
2	Antihypertensive Agents (Antihypertensives)IBA 01/2003 - 01/2002
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 07/2002 - 01/2002
1	Biomarkers (Surrogate Marker)IBA 11/2017
1	Telmisartan (Micardis)FDA Link 08/2012
1	alpha 1 Chain Collagen Type IIBA 10/2005
1	PyridoxamineIBA 10/2005
1	SaltsIBA 10/2005
1	Advanced Oxidation Protein Products (AOPP)IBA 10/2005
1	Extracellular Matrix ProteinsIBA 09/2004
1	MibefradilIBA 09/2004
1	NF-kappa B (NF-kB)IBA 08/2004
1	Platelet-Derived Growth FactorIBA 05/2004
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 05/2004
1	Imatinib Mesylate (Gleevec)FDA Link 05/2004
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 02/2004
1	Oxygen (Dioxygen)IBA 09/2003
1	CreatinineIBA 08/2003
1	AngiotensinsIBA 08/2003
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2003
1	Glutathione PeroxidaseIBA 06/2003
1	OsteopontinIBA 06/2003
1	Angiotensin II Type 1 Receptor BlockersIBA 01/2003
1	PorinsIBA 01/2003
1	Verapamil (Calan)FDA LinkGeneric 01/2003
1	Fibronectins (Fibronectin)IBA 12/2002
1	pimagedine (aminoguanidine)IBA 12/2002
1	CytokinesIBA 12/2002
1	ApolipoproteinsIBA 07/2002
1	ReninIBA 04/2002
1	Atrial Natriuretic Factor (ANF)IBA 04/2002
1	Angiotensin Receptor AntagonistsIBA 01/2002

Therapy/Procedure

4	Therapeutics 04/2024 - 01/2002